Inventor
ISLAM IMADUL
IN29 patents
⚠️ This page may combine multiple inventors who share the name “ISLAM IMADUL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING AG
15 patentsUS6207665B1Mar 27, 2001
Piperazine derivatives and their use as anti-inflammatory agents
SCHERING AG89 citations98
US6861424B2Mar 1, 2005
Platelet adenosine diphosphate receptor antagonists
SCHERING AG19 citations92
US6555537B2Apr 29, 2003
Piperazine derivatives and their use as anti-inflammatory agents
SCHERING AG24 citations92
US6534509B1Mar 18, 2003
Piperazine derivatives and their use as anti-inflammatory agents
SCHERING AG19 citations92
US7026323B2Apr 11, 2006
Platelet adenosine diphosphate receptor antagonists
SCHERING AG8 citations73
US6541476B1Apr 1, 2003
Piperazine derivatives and their use as anti-inflammatory agents
SCHERING AG3 citations73
US7105563B2Sep 12, 2006
Indolinone derivatives and their use in treating disease-states such as cancer
SCHERING AG10 citations70
US6995156B2Feb 7, 2006
Platelet adenosine diphosphate receptor antagonists
SCHERING AG2 citations62
US7268140B2Sep 11, 2007
Piperazine derivatives and their use as anti-inflammatory agents
SCHERING AG0 citations52
US6977258B2Dec 20, 2005
Piperazine derivatives and their use as anti-inflammatory agents
SCHERING AG0 citations52
US6972290B2Dec 6, 2005
Piperazine derivatives and their use as anti-inflammatory agents
SCHERING AG0 citations52
US6573266B1Jun 3, 2003
Piperazine derivatives and their use as anti-inflammatory agents
SCHERING AG0 citations52
US7084142B2Aug 1, 2006
Platelet adenosine diphosphate receptor antagonists
SCHERING AG0 citations51
US7056923B2Jun 6, 2006
Platelet adenosine diphosphate receptor antagonists
SCHERING AG0 citations51
US7176207B2Feb 13, 2007
Platelet adenosine diphosphate receptor antagonists
SCHERING AG0 citations49
BRISTOL MYERS SQUIBB CO
6 patentsUS9221796B2Dec 29, 2015
Selective NR2B antagonists
BRISTOL MYERS SQUIBB CO5 citations72
US8722670B2May 13, 2014
Selective NR2B antagonists
BRISTOL MYERS SQUIBB CO2 citations62
US10954225B2Mar 23, 2021
Selective NR2B antagonists
BRISTOL MYERS SQUIBB CO0 citations60
US10961229B2Mar 30, 2021
Selective NR2B antagonists
BRISTOL MYERS SQUIBB CO0 citations59
US10344020B2Jul 9, 2019
Selective NR2B antagonists
BRISTOL MYERS SQUIBB CO1 citations59
US10501451B2Dec 10, 2019
Selective NR2B antagonists
BRISTOL MYERS SQUIBB CO0 citations50
SYNAPTIC PHARMA CORP
3 patentsUS6391877B1May 21, 2002
Aryl sulfonamides and sulfamide derivatives and uses thereof
SYNAPTIC PHARMA CORP52 citations96
US6211241B1Apr 3, 2001
Aryl sulfonamides and sulfamide derivatives and uses thereof
SYNAPTIC PHARMA CORP58 citations96
US6734182B2May 11, 2004
Aryl sulfonamides and sulfamide derivatives and uses thereof
SYNAPTIC PHARMA CORP0 citations52